Improvement in Hepatic Encephalopathy with Rifaximin Is Associated with Distinct Changes in the Metagenomic Species in the Saliva and Stool Microbiome and a Reduction in Systemic Inflammation - Results of the Rifsys Randomized Controlled Trial.
HEPATOLOGY（2018）
Key words
rifaximin,hepatic encephalopathy,microbiome,systemic inflammation
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined